175 related articles for article (PubMed ID: 34982455)
1. Warfarin adherence and anticoagulation control in atrial fibrillation patients: a systematic review.
Ababneh M; Nasser SA; Rababa'h A; Ababneh F
Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):7926-7933. PubMed ID: 34982455
[TBL] [Abstract][Full Text] [Related]
2. Anticoagulation Control, Outcomes, and Associated Factors in Patients with Atrial Fibrillation Receiving Warfarin at Tertiary Care Hospital in Ethiopia.
Yimer NS; Abiye AA; Hussen SU; Tadesse TA
Clin Appl Thromb Hemost; 2021; 27():10760296211049786. PubMed ID: 34724849
[TBL] [Abstract][Full Text] [Related]
3. Patients' and clinicians' perceptions of oral anticoagulants in atrial fibrillation: a systematic narrative review and meta-analysis.
Osasu YM; Cooper R; Mitchell C
BMC Fam Pract; 2021 Dec; 22(1):254. PubMed ID: 34937557
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis to assess the quality of warfarin control in atrial fibrillation patients in the United States.
Baker WL; Cios DA; Sander SD; Coleman CI
J Manag Care Pharm; 2009 Apr; 15(3):244-52. PubMed ID: 19326955
[TBL] [Abstract][Full Text] [Related]
5. Anticoagulation adherence and its associated factors in patients with atrial fibrillation: a cross-sectional study.
Chen PT; Wang TJ; Hsieh MH; Liu JC; Liu CY; Wang KY; Laio WC
BMJ Open; 2019 Sep; 9(9):e029974. PubMed ID: 31481562
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Patient-Reported Care Satisfaction, Quality of Warfarin Therapy, and Outcomes of Atrial Fibrillation: Findings From the ORBIT - AF Registry.
Perino AC; Shrader P; Turakhia MP; Ansell JE; Gersh BJ; Fonarow GC; Go AS; Kaiser DW; Hylek EM; Kowey PR; Singer DE; Thomas L; Steinberg BA; Peterson ED; Piccini JP; Mahaffey KW
J Am Heart Assoc; 2019 May; 8(9):e011205. PubMed ID: 31023126
[TBL] [Abstract][Full Text] [Related]
7. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
[TBL] [Abstract][Full Text] [Related]
8. Cost effectiveness of novel oral anticoagulants for stroke prevention in atrial fibrillation depending on the quality of warfarin anticoagulation control.
Janzic A; Kos M
Pharmacoeconomics; 2015 Apr; 33(4):395-408. PubMed ID: 25512096
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the impact of warfarin time in therapeutic range on outcomes of patients with atrial fibrillation in Turkey: perspectives from the observational, prospective WATER Registry.
Turk UO; Tuncer E; Alioglu E; Yuksel K; Pekel N; Ozpelit E; Vuran O; Tengiz I
Cardiol J; 2015; 22(5):567-75. PubMed ID: 26100825
[TBL] [Abstract][Full Text] [Related]
10. Persistence and outcomes of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with non-valvular atrial fibrillation.
Wu S; Xie S; Xu Y; Que D; Yau TO; Wang L; Huang Y
J Clin Nurs; 2019 May; 28(9-10):1839-1846. PubMed ID: 30667111
[TBL] [Abstract][Full Text] [Related]
11. Impact of adherence to warfarin therapy during 12 weeks of pharmaceutical care in patients with poor time in the therapeutic range.
Marcatto L; Boer B; Sacilotto L; Olivetti N; Darrieux FCC; Scanavacca MI; Pereira AC; Santos PCJL
J Thromb Thrombolysis; 2021 May; 51(4):1043-1049. PubMed ID: 32974757
[TBL] [Abstract][Full Text] [Related]
12. Factors Affecting Patients' Perception On, and Adherence To, Anticoagulant Therapy: Anticipating the Role of Direct Oral Anticoagulants.
Pandya EY; Bajorek B
Patient; 2017 Apr; 10(2):163-185. PubMed ID: 27438598
[TBL] [Abstract][Full Text] [Related]
13. Patient Adherence to Novel Oral Anticoagulants (NOACs) for the Treatment of Atrial Fibrillation and Occurrence of Associated Bleeding Events: A Systematic Review and Meta-analysis.
Shehab A; Bhagavathula AS; Abebe TB; Abegaz TM; Elnour AA; Sabbour HM; Uzzafer M; Hersi A; Hamad AK
Curr Vasc Pharmacol; 2019; 17(4):341-349. PubMed ID: 29359674
[TBL] [Abstract][Full Text] [Related]
14. Modelling the cost-effectiveness of pharmacist-managed anticoagulation service for older adults with atrial fibrillation in Singapore.
Chua WB; Cheen HH; Kong MC; Chen LL; Wee HL
Int J Clin Pharm; 2016 Oct; 38(5):1230-40. PubMed ID: 27461367
[TBL] [Abstract][Full Text] [Related]
15. Decreased risk of renal impairment in atrial fibrillation patients receiving non-vitamin K antagonist oral anticoagulants: A pooled analysis of randomized controlled trials and real-world studies.
Zhang C; Gu ZC; Ding Z; Shen L; Pan MM; Zheng YL; Lin HW; Pu J
Thromb Res; 2019 Feb; 174():16-23. PubMed ID: 30551039
[TBL] [Abstract][Full Text] [Related]
16. Medication taking behaviors in patients taking warfarin versus direct oral anticoagulants: A systematic review.
Mohan A; Wanat MA; Abughosh SM
Expert Rev Cardiovasc Ther; 2019 Jun; 17(6):427-434. PubMed ID: 31100208
[No Abstract] [Full Text] [Related]
17. Differences in attitude, education, and knowledge about oral anticoagulation therapy among patients with atrial fibrillation in Europe: result of a self-assessment patient survey conducted by the European Heart Rhythm Association.
Hernández Madrid A; Potpara TS; Dagres N; Chen J; Larsen TB; Estner H; Todd D; Bongiorni MG; Sciaraffia E; Proclemer A; Cheggour S; Amara W; Blomstrom-Lundqvist C
Europace; 2016 Mar; 18(3):463-7. PubMed ID: 26899998
[TBL] [Abstract][Full Text] [Related]
18. Racial Differences in Quality of Anticoagulation Therapy for Atrial Fibrillation (from the TREAT-AF Study).
Yong C; Azarbal F; Abnousi F; Heidenreich PA; Schmitt S; Fan J; Than CT; Ullal AJ; Yang F; Phibbs CS; Frayne SM; Ho PM; Shore S; Mahaffey KW; Turakhia MP
Am J Cardiol; 2016 Jan; 117(1):61-8. PubMed ID: 26552504
[TBL] [Abstract][Full Text] [Related]
19. Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation with Coronary or Peripheral Artery Disease.
Zhang H; Xue Z; Yi D; Li X; Tan Y; Li J
Int Heart J; 2020 Mar; 61(2):231-238. PubMed ID: 32173695
[TBL] [Abstract][Full Text] [Related]
20. Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Cancer and Atrial Fibrillation: A Systematic Review and Meta-Analysis.
Deng Y; Tong Y; Deng Y; Zou L; Li S; Chen H
J Am Heart Assoc; 2019 Jul; 8(14):e012540. PubMed ID: 31310583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
